Claims for Patent: 5,962,427

Summary for Patent: 5,962,427

Title:	In vivo gene transfer methods for wound healing
Abstract:	The present invention relates to an in vivo method for specific targeting and transfer of DNA into mammalian repair cells. The transferred DNA may include any DNA encoding a therapeutic protein of interest. The invention is based on the discovery that mammalian repair cells proliferate and migrate into a wound site where they actively take up and express DNA. The invention further relates to pharmaceutical compositions that may be used in the practice of the invention to transfer the DNA of interest. Such compositions include any suitable matrix in combination with the DNA of interest.
Inventor(s):	Goldstein; Steven A. (Ann Arbor, MI), Bonadio; Jeffrey (Ann Arbor, MI)
Assignee:	The Regent of the University of Michigan (Ann Arbor, MI)
Application Number:	08/631,334
Patent Claims:	1. A method for transferring a DNA molecule that directs the expression of a gene product into a mammalian repair cell, comprising applying a biocompatible matrix containing the DNA molecule to a wound in a mammalian subject, so that repair cells at the wound site acquire the DNA molecule, and express the gene product in vivo. 2. The method of claim 1 wherein the biocompatible matrix is collagenous, metal, hydroxyapatite, bioglass, aluminate, bioceramic materials, purified proteins or extracellular matrix compositions. 3. The method of claim 1 wherein the biocompatible matrix is collagen. 4. The method of claim 3 wherein the collagen is type II collagen. 5. The method of claim 1 wherein the DNA molecule encodes a therapeutic protein. 6. The method of claim 1 wherein the DNA molecule encodes a growth factor. 7. The method of claim 1 wherein the DNA molecule is more than one DNA molecule. 8. The method of claim 6 wherein the growth factor is transforming growth factor-.beta.eta (TGF-.beta.), fibroblast growth factor (FGF), platelet derived growth factor (PDGF), insulin like growth factor (IGF), or bone morphogenic factor (BMP). 9. The method of claim 5 wherein the therapeutic protein is a hormone. 10. The method of claim 9 wherein the hormone is growth hormone (GH). 11. The method of claim 9 wherein the hormone is human parathyroid hormone (PTH). 12. The method of claim 1, wherein said wound site is a site of connective tissue injury. 13. The method of claim 1, wherein said wound site is a site of organ damage. 14. A method for transferring a DNA molecule that directs the expression of a gene product into a mammalian repair cell, comprising applying a biocompatible matrix containing the DNA molecule to a wound in a mammalian subject, wherein said matrix is sufficient to allow infiltration of repair cells, so that repair cells at the wound site acquire the DNA molecule, and express the gene product in vivo.

Details for Patent 5,962,427

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Nps Pharmaceuticals, Inc.	NATPARA	parathyroid hormone	For Injection	125511	01/23/2015		2014-02-18